These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5147583)

  • 21. The effect of chlorambucil on the incorporation of tritiated precursors into the nucleic acids and proteins of Yoshida ascites sarcoma cells.
    Hill BT; Harrap KR
    Neoplasma; 1970; 17(5):485-9. PubMed ID: 5486299
    [No Abstract]   [Full Text] [Related]  

  • 22. The estimation of human tumors sensitivity to cytostatic treatment. II. The influencing of 125-I iododeoxyuridine incorporation by cytostatics in experimental tumors.
    Andrýsek O; Motycka K; Dvorák O; Jandová A; Stránská E
    Neoplasma; 1969; 16(1):57-61. PubMed ID: 5786510
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytomorphological effect of several antitumor substances on Yoshida ascites sarcoma in rats.
    SHIMA T
    J Antibiot (Tokyo); 1959 Jul; 12():142-59. PubMed ID: 13854799
    [No Abstract]   [Full Text] [Related]  

  • 24. [Rate of formation of free and membrane-bound polysomes in rat liver cells and in cells of Yoshidas ascites hepatoma AH 130].
    Marsilii G; Pierro Dini G; Cappelletti R
    Sperimentale; 1970; 120(4):219-36. PubMed ID: 5527196
    [No Abstract]   [Full Text] [Related]  

  • 25. Estimation of sensitivity of human tumors to cytostatics in vitro. I.
    Andrysek O; Jandová A; Motycka K; Slavík K
    Neoplasma; 1968; 15(1):59-69. PubMed ID: 5650630
    [No Abstract]   [Full Text] [Related]  

  • 26. Modification of cancer cells radiosensitivity. I. A study of Crabtree effect in Yoshida ascites sarcoma cells.
    Watras J; Widel M
    Radiol Diagn (Berl); 1972; 13(2):241-9. PubMed ID: 5046291
    [No Abstract]   [Full Text] [Related]  

  • 27. Modification of cancer cells radiosensitivity. I. A study of carbtree effect in yoshida ascites sarcoma cells.
    Watras J; Widel M
    Radiobiol Radiother (Berl); 1972; 13(2):241-9. PubMed ID: 4636561
    [No Abstract]   [Full Text] [Related]  

  • 28. [Basic differences in the effect of cellular parameters on the incorporation of strongly and weakly incorporated pharmaco].
    Kreye VA
    Arzneimittelforschung; 1968 Nov; 18(11):1391-6. PubMed ID: 5755902
    [No Abstract]   [Full Text] [Related]  

  • 29. Host-tumour relationship. XXI. Proteins distribution according to molecule size between the serum and ascites fluid in the course of development of Yoshida ascites tumours in rats.
    Dolezalová V; Brada Z
    Neoplasma; 1966 Jan; 13(1):35-43. PubMed ID: 5929877
    [No Abstract]   [Full Text] [Related]  

  • 30. [Amino acids in the ascites of the Yoshida tumor].
    FERRINI U; MARCANTE ML
    Boll Soc Ital Biol Sper; 1963 Jan; 39():54-5. PubMed ID: 13944926
    [No Abstract]   [Full Text] [Related]  

  • 31. Uptake of P into tissue constituents of rats bearing Yoshida ascites tumour.
    Sankaran K; Pawse AR; Nadkarni GB
    Indian J Biochem Biophys; 1977 Sep; 14(3):298-9. PubMed ID: 612545
    [No Abstract]   [Full Text] [Related]  

  • 32. [The effect of 2,3,5-triethyleneimonobenzoquinone (1,4) on the incorporation of C14-labelled amino acids into the protein of anaerobic glycolizing Yoshida ascites tumors cells].
    HOELZEL F
    Z Naturforsch B; 1961 Dec; 16B():792-801. PubMed ID: 14036273
    [No Abstract]   [Full Text] [Related]  

  • 33. [Substances with antineoplastic effect. 29. N-delta-6-purinylthio valeryl-amino acids and analogous dipeptide and triglycerin derivatives].
    Semonský M; Cerný A; Jelínek V
    Arzneimittelforschung; 1970 Mar; 20(3):316-23. PubMed ID: 5468410
    [No Abstract]   [Full Text] [Related]  

  • 34. Isolation of alpha-fetoprotein-producing cells from Yoshida ascites sarcoma and its clone.
    Isaka H; Umehara S; Hirai H; Tsukada Y; Watabe H
    Gan; 1973 Apr; 64(2):133-8. PubMed ID: 4198814
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of variant tumor cells of Yoshida ascites sarcoma producing -fetoprotein.
    Isaka H; Umehara S; Hirai H; Tsukada Y
    Gan; 1972 Feb; 63(1):63-71. PubMed ID: 4114562
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of several anticarcinogenic compounds on Yoshida ascites sarcoma cells and the therapeutic effect of anticancer agents with different mode of action on Yoshida sarcoma animals].
    HARADA K
    Tohoku Igaku Zasshi; 1961 Nov; 64():540-53. PubMed ID: 13952690
    [No Abstract]   [Full Text] [Related]  

  • 37. Modification of cancer cells radiosensitivity. II. Influence of the crabtree effect on radiosensitivity of Yoshida ascites sarcoma cells.
    Watras J; Widel M
    Radiobiol Radiother (Berl); 1973; 14(1):73-8. PubMed ID: 4689210
    [No Abstract]   [Full Text] [Related]  

  • 38. [High voltage electrophoretic study of amino acids in the interstitial fluid of rat neoplasms].
    Hofmann F; Büchner M; Scheid P
    Acta Biol Med Ger; 1971; 27(4):801-3. PubMed ID: 5141648
    [No Abstract]   [Full Text] [Related]  

  • 39. Abolition by actinomycin D pretreatment in vivo of the stimulating effect of serum proteins on the protein synthesis of Yoshida ascites hepatoma in vitro.
    Marsilii G; Chiarugi V
    Biochem J; 1966 Jul; 100(1):1C-2C. PubMed ID: 4290532
    [No Abstract]   [Full Text] [Related]  

  • 40. Chromosomal features and DNA content of Yoshida ascites sarcoma and its slow-growing variants characterized by island formation in ascites.
    Isaka H
    Gan; 1968 Aug; 59(4):327-39. PubMed ID: 5707407
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.